The Kimmel Cancer Center will host the inaugural “Eyes on a Cure: Patient and Caregiver Symposium” on June 16 and 17.
The symposium will bring uveal melanoma patients, caregivers, and researchers from around the world together to offer educational sessions, support groups led by oncology social workers, sessions on complementary therapies, as well as informal time for networking.
Uveal melanoma, also known as ocular melanoma (OM), is diagnosed in about 2,000 people a year in this country. Though rare, it is the most common eye cancer in adults.
Over 100 patients, along with their families, are expected to attend the event.
The Kimmel Cancer Center at Jefferson is a major center for the treatment of OM. Medical oncologist Takami Sato, MD, PhD, one of the leading specialists in the disease,has seen more than 100 new patients with metastatic uveal melanoma every year since 1999.
David Eschelman, MD, and Carin F. Gonsalves, MD of the Division of Cardio-Interventional Radiology at Jefferson, have performed more than 300 embolization procedures for the liver metastases from uveal melanoma last year.
And the Jefferson team works closely with Jerry Shields, M., and Carol Shields, MD, of Wills Eye Institute in Philadelphia, who see more than 500 patients with primary uveal melanoma every year.
All are scheduled to speak over the course of the two days.
“Not many patients know about the disease and many have struggled with finding an appropriate treatment,” says Dr. Sato. “This is an opportunity to educate, as well as provide patients with support from both social workers and doctors—and hopefully foster research collaborations and funding opportunities. We are very honored to be hosting it.”
Director of CURE OM Sara Selig, Timothy Turnham, Ph.D., the Executive Director of the Melanoma Research Foundation, Daniel Brown, MD, of the Department of Interventional Radiology, and Rani Anne, M.D., of the Department of Radiation Oncology will also speak.
To learn more about the CURE OM Conference at the Kimmel Cancer Center click here.
To read the blog post about Sara Selig and her husband’s battle with OM and their efforts to bring more attention to the disease, click here.